DCF — ST CHARLES MEDICAL CENTER
Enterprise Value: $351.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$351.4M
Enterprise Value
$84.8M
PV of Cash Flows
$266.6M
PV of Terminal Value
$429.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $753.4M | $52.7M | 7.0% | $12.4M | $11.3M |
| Year 2 | $776.0M | $62.1M | 8.0% | $18.6M | $15.3M |
| Year 3 | $799.3M | $71.9M | 9.0% | $25.1M | $18.9M |
| Year 4 | $823.3M | $78.2M | 10.0% | $29.0M | $19.8M |
| Year 5 | $848.0M | $82.7M | 10.0% | $31.4M | $19.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $351.4M. Terminal value accounts for 76% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$731.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.06501051761350433
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5